ロード中...
Regorafenib as Salvage Treatment in Korean Patients with Refractory Metastatic Colorectal Cancer
PURPOSE: Regorafenib, an oral multi-targeted tyrosine kinase inhibitor, is considered the new standard of care in patients with chemotherapy-refractory colorectal cancers (CRCs). However, there are no data on this drug in Korean patients. MATERIALS AND METHODS: We evaluated patients who received ora...
保存先:
| 出版年: | Cancer Res Treat |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Korean Cancer Association
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4614225/ https://ncbi.nlm.nih.gov/pubmed/25672574 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2014.126 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|